Angelini Pharma announces the acquisition of two Sanofi CHC brands in Germany and Austria for a total of € 47 M.
Sumitomo Dainippon Pharma Co., Ltd. and Angelini S.p.A. announced today that the companies have formed a partnership with the goal to expand availability in Europe of Latuda®.
The new acid-oxidizing solution containing hypoclorous acid and intended for cleansing various kind of wounds, including diabetic foot ulcers, pressure and vascular ulcers, has arrived in Italy.
The depression affects 7.5 million people namely 12.5% of the population in Italy. According to the World Health Organisation (WHO) this illness is the first reason of disability nowadays.
Angelini, IRBM Science Park, IBN Savio and Ylichron created the AICI project